Phase 1 study of lonafarnib (SCH 66336) and imatinib mesylate in patients with chronic myeloid leukemia who have failed prior single-agent therapy with imatinib.

Venue / Journal

Cancer

Date

Sat, 09/15/2007 - 12:00

Additional Journal Information

110(6):1295-302

Authors

Cortes J, Jabbour E, Daley GQ, O'Brien S, Verstovsek S, Ferrajoli A, Koller C, Zhu Y, Statkevich P, Kantarjian H.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/17623836